ask="6.230"
ask_size="100"
average_daily_volume="25778"
bid="5.970"
bid_size="3000"
book_value="1.808"
change="+0.095"
change_from_200_day_moving_average="-0.488"
change_from_50_day_moving_average="-0.101"
change_from_52_week_high="-4.295"
change_From_52_week_low="0.515"
change_in_percent="+1.552%"
close="6.215"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.860"
ebitda="-9.95M"
eps_estimate_current_year="-0.620"
eps_estimate_next_quarter="-0.170"
eps_estimate_next_year="-1.010"
ex_dividend_date="N/A"
float_shares="8775000"
high="6.420"
high_52_weeks="10.510"
last_trade_date="3/2/2017"
last_trade_price="6.215"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.110"
low_52_weeks="5.700"
market_capitalization="82.55M"
moving_average_200_day="6.703"
moving_average_50_day="6.316"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.000"
open="6.110"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-7.283%"
percent_change_from_50_day_moving_average="-1.593%"
percent_change_from_52_week_high="-40.866%"
percent_change_from_52_week_low="+9.035%"
previous_close="6.120"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.385"
price_per_sales="64.982"
revenue="1.25M"
shares_outstanding="13283000"
short_ratio="11.970"
stock_exchange="NCM"
symbol="ORMP"
volume="16689"
weeks_range_52="5.700 - 10.510"
